Introduction: II Florence Meeting on Advances in Cardiomyopathies
I am honoured and delighted to be asked by the Italian Study Group on Cardiomyopathies and Professors Baroldi, Camerini and De Vita to take part in this important meeting. Cardiomyopathies go from strength to strength in their importance. I well recall that, when involved in planning the Scientific Programme for the World Congress of Cardiology in 1970, I proposed a Session on Cardiomyopathies, a suggestion that was greeted without enthusiasm! Now large lecture theatres at major Cardiological meetings are filled to capacity when the topic is Cardiomyopathies. Fifty years ago or so, Proctor Harvey, Burch and Mattingly in the United States were studying cases of heart muscle disease of unknown cause. Brigden gave his St Cyres lecture in 1957 on “uncommon myocardial diseases ”. Teare described asymmetric hypertrophy of the heart, now known as hypertrophic cardiomyopathy and Brock was operating to relieve muscular sub-aortic obstruction. But what we now recognise as hypertrophic cardiomyopathy was probably first discovered by Liouville in 1869 .
KeywordsUnited States Sudden Death Ventricular Hypertrophy Dilate Cardiomyopathy Hypertrophic Cardiomyopathy
- 1.Liouville H (1869) Rétrécissement cardiaque sous aortique. Gazette Med Paris 24.61Google Scholar
- 3.Olsen EGJ, Goodwin JF (1993) Definition, classification and terminology. In: Goodwin JF, Olsen EGJ (eds) Cardiomyopathies — Realisations and expectations. Springer-Verlag, Heidelberg, pp 3–5Google Scholar